Discovery of 2,3‐Dihydro‐1H‐indene Derivatives as Novel GPR40 Agonists

Arturo D Mancini, Gyslaine Bertrand, Kevin Vivot, Éric Carpentier, Caroline Tremblay, Julien Ghislain, Michel Bouvier, Vincent Poitout, None, β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1. Journal of Biological Chemistry. ,vol. 290, pp. 21131- 21140 ,(2015) , 10.1074/JBC.M115.644450

Michael J. Waring, John Arrowsmith, Andrew R. Leach, Paul D. Leeson, Sam Mandrell, Robert M. Owen, Garry Pairaudeau, William D. Pennie, Stephen D. Pickett, Jibo Wang, Owen Wallace, Alex Weir, An analysis of the attrition of drug candidates from four major pharmaceutical companies Nature Reviews Drug Discovery. ,vol. 14, pp. 475- 486 ,(2015) , 10.1038/NRD4609

Sarah R. Langdon, Nathan Brown, Julian Blagg, Scaffold Diversity of Exemplified Medicinal Chemistry Space Journal of Chemical Information and Modeling. ,vol. 51, pp. 2174- 2185 ,(2011) , 10.1021/CI2001428

Jonathan B Houze, Liusheng Zhu, Ying Sun, Michelle Akerman, Wei Qiu, Alex J Zhang, Rajiv Sharma, Michael Schmitt, Yingcai Wang, Jiwen Liu, Jinqian Liu, Julio C Medina, Jeff D Reagan, Jian Luo, George Tonn, Jane Zhang, Jenny Ying-Lin Lu, Michael Chen, Edwin Lopez, Kathy Nguyen, Li Yang, Liang Tang, Hui Tian, Steven J Shuttleworth, Daniel C-H Lin, None, AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorganic & Medicinal Chemistry Letters. ,vol. 22, pp. 1267- 1270 ,(2012) , 10.1016/J.BMCL.2011.10.118

Tetsuto Tsunoda, Yoshiko Yamamiya, Shô Itô, 1,1′-(azodicarbonyl)dipiperidine-tributylphosphine, a new reagent system for mitsunobu reaction Tetrahedron Letters. ,vol. 34, pp. 1639- 1642 ,(1993) , 10.1016/0040-4039(93)85029-V

Maria Hauge, Marie A. Vestmar, Anna S. Husted, Jeppe P. Ekberg, Michael J. Wright, Jerry Di Salvo, Adam B. Weinglass, Maja S. Engelstoft, Andreas N. Madsen, Michael Lückmann, Michael W. Miller, Maria E. Trujillo, Thomas M. Frimurer, Birgitte Holst, Andrew D. Howard, Thue W. Schwartz, GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo Molecular metabolism. ,vol. 4, pp. 3- 14 ,(2015) , 10.1016/J.MOLMET.2014.10.002

Marc Rendell, The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus Drugs. ,vol. 64, pp. 1339- 1358 ,(2004) , 10.2165/00003495-200464120-00006

Akio Fujii, Shohei Hashiguchi, Nobuyuki Uematsu, Takao Ikariya, Ryoji Noyori, Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation of Ketones Using a Formic Acid−Triethylamine Mixture Journal of the American Chemical Society. ,vol. 118, pp. 2521- 2522 ,(1996) , 10.1021/JA954126L

Stephen A. Hitchcock, Lewis D. Pennington, Structure-brain exposure relationships. Journal of Medicinal Chemistry. ,vol. 49, pp. 7559- 7583 ,(2006) , 10.1021/JM060642I

Nobuyuki Negoro, Shinobu Sasaki, Satoshi Mikami, Masahiro Ito, Masami Suzuki, Yoshiyuki Tsujihata, Ryo Ito, Ayako Harada, Koji Takeuchi, Nobuhiro Suzuki, Junichi Miyazaki, Takashi Santou, Tomoyuki Odani, Naoyuki Kanzaki, Miyuki Funami, Toshimasa Tanaka, Akifumi Kogame, Shinichiro Matsunaga, Tsuneo Yasuma, Yu Momose, Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist ACS Medicinal Chemistry Letters. ,vol. 1, pp. 290- 294 ,(2010) , 10.1021/ML1000855